SCIESCOPUSQ1
MedComm
WILEY, United States
MedComm is an academic journal published by WILEY (United States). Identifiers: eISSN 2688-2663. Indexed in SCIE, SCOPUS. Metrics: JIF 10.7, CiteScore 8.8, SJR 2.469, SNIP 1.65. Subject areas: MEDICINE, RESEARCH & EXPERIMENTAL. tlooto lists 2,150 papers from this journal.
CiteScore
8.80
Scopus citation metric
SJR
2.469
SCImago rank
SNIP
1.65
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- -
- eISSN
- 2688-2663
- Abbreviation
- MEDCOMM
- Publisher
- WILEY
- Country
- United States
Web of Science categories
No Web of Science category data available.
Scopus ASJC categories
1307 Cell Biology1311 Genetics2704 Biochemistry (medical)2716 Genetics (clinical)2723 Immunology and Allergy2730 Oncology3002 Drug Discovery
Papers in this journal
Recent papers
- An Engineered Extracellular Vesicle With Enhanced Tumor and Lymph Nodes Targeting as siRNA Delivery System for Robust Tumor Immunotherapy
2026
- Progress in RNA‐Targeted Therapeutics for Human Diseases
2026 · 4 citations
- Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway
2026
- HSD17B7 Counters Bone Loss in Estrogen Deficiency via Estrogen Receptor Stabilization and Mediates the Effect of Raloxifene
2026
- Isocitrate Dehydrogenase Mutations in Cancer: From Bench to Bedside Applications
2026 · 1 citations
Most cited papers
- Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities
2022 · 616 citations
- Nanoparticles‐induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models
2023 · 556 citations
- NF‐κB signaling in inflammation and cancer
2021 · 504 citations
- SARS‐CoV‐2 Omicron variant: Characteristics and prevention
2021 · 446 citations
- Applications of multi‐omics analysis in human diseases
2023 · 409 citations